Luca Tagliaferri

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 307 publications

A Decade of Interventional Radiotherapy (Brachytherapy): Progress, Challenges, and Future Prospects - A Bibliometric Analysis.

A Decade of Interventional Radiotherapy (Brachytherapy): Progress, Challenges, and Future Prospects - A Bibliometric Analysis.

Journal: Technology in cancer research & treatment

Published: July 21, 2026

Revisiting the Abscopal Effect in the Era of Immuno-Radiotherapy: Mechanisms, Challenges, and Clinical Perspectives.

Revisiting the Abscopal Effect in the Era of Immuno-Radiotherapy: Mechanisms, Challenges, and Clinical Perspectives.

Journal: Biomolecules

Published: July 02, 2026

D90 and D2CC Dose in Vaginal CTV as Dosimetric Predictors of Late Vaginal Side Effects in Postoperative Vaginal Modern Brachytherapy (Interventional Radiotherapy) After External Beam Irradiation in Endometrial Cancer.

D90 and D2CC Dose in Vaginal CTV as Dosimetric Predictors of Late Vaginal Side Effects in Postoperative Vaginal Modern Brachytherapy (Interventional Radiotherapy) After External Beam Irradiation in Endometrial Cancer.

Journal: Cancers

Published: June 16, 2026

A Narrative Review of da Vinci Single-Port Versus Multi-Port Robotic Surgery in Elderly or Frail Urological Cancer Patients.

A Narrative Review of da Vinci Single-Port Versus Multi-Port Robotic Surgery in Elderly or Frail Urological Cancer Patients.

Journal: Cancers

Published: June 14, 2026

The ITALIC-RCC: A Randomized Trial on Clinical and Humoral Impact of Primary Tumor Ablation by Surgery or Radiotherapy in Metastatic Renal Cell Carcinoma Treated with Checkpoint Inhibitors.

The ITALIC-RCC: A Randomized Trial on Clinical and Humoral Impact of Primary Tumor Ablation by Surgery or Radiotherapy in Metastatic Renal Cell Carcinoma Treated with Checkpoint Inhibitors.

Journal: European urology open science

Published: June 08, 2026

Skin Cosmesis assessment tools and methods in patients with non-melanoma skin cancers treated with radiotherapy: Systematic review on behalf of the ESTRO skin and soft tissue focus group and the GEC-ESTRO head and neck and skin working group.

Skin Cosmesis assessment tools and methods in patients with non-melanoma skin cancers treated with radiotherapy: Systematic review on behalf of the ESTRO skin and soft tissue focus group and the GEC-ESTRO head and neck and skin working group.

Journal: Clinical and translational radiation oncology

Published: May 17, 2026

Corrigendum to "International multicentric validation of a novel T classification system for cancer of the nasal vestibule"[Eur J Cancer 235 (2026), 116245].

Corrigendum to "International multicentric validation of a novel T classification system for cancer of the nasal vestibule"[Eur J Cancer 235 (2026), 116245].

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 14, 2026

European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention - Update 2026.

European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention - Update 2026.

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 19, 2026

European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment - update 2026.

European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment - update 2026.

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 19, 2026

Correction: Schubert et al. Minimally Invasive Ablation Strategies for Renal Cell Carcinoma Patients Ineligible for Surgery. Life 2026, 16, 73.

Correction: Schubert et al. Minimally Invasive Ablation Strategies for Renal Cell Carcinoma Patients Ineligible for Surgery. Life 2026, 16, 73.

Journal: Life (Basel, Switzerland)

Published: March 05, 2026

Development of an Enomogram to Predict the Rate of Loco-Regional Control After Radio-Chemotherapy and Interventional Radiotherapy in Cervical Cancer.

Development of an Enomogram to Predict the Rate of Loco-Regional Control After Radio-Chemotherapy and Interventional Radiotherapy in Cervical Cancer.

Journal: Cancers

Published: February 26, 2026

SBRT plus abiraterone acetate and ADT versus abiraterone acetate and ADT in oligometastatic castrate-resistant prostate cancer (ARTO): long-term, unplanned overall survival analysis of an open-label, randomised, phase 2 trial.

SBRT plus abiraterone acetate and ADT versus abiraterone acetate and ADT in oligometastatic castrate-resistant prostate cancer (ARTO): long-term, unplanned overall survival analysis of an open-label, randomised, phase 2 trial.

Journal: The Lancet. Oncology

Published: February 17, 2026

Showing 1-12 of 307

Last Updated: 09/26/2026